Dr. Cl?ona Murphy:

It would not be our role to lift the pause. The CMO called for the pause in the first place for good reasons. Should the pause be lifted, we would be talking about a different landscape. We would be talking about tighter guidelines, designated people who would be approved to insert mesh under strict controls. It would involve a database of those mesh. As a clinician group, we are aware that there is a large number of people who are suffering from stress urinary incontinence, SUI, symptoms, for whom conservative measures have failed.

Mesh is recommended by a number of professional groups as an appropriate management for stress urinary incontinence, so there is that other competing interest of large numbers of women also in clinics suffering from incontinence. The landscape, controls, oversight and data collection would be different.